No Data Available
Lasa Supergenerics Share Price
| Open | 7.60 |
| High | 7.95 |
| Low | 7.41 |
| Prev Close | 7.60 |
| Volume | 19,598 |
| VWAP(₹) | 7.67 |
Key Metrics
| PE Ratio(x) | -1.13 |
| EPS - TTM(₹) | -6.80 |
| MCap(₹ Cr.) | 38.53 |
| MCap Rank | 104 |
| PB Ratio(x) | 0.77 |
| Div Yield(%) | - |
| Face Value(₹) | 10.00 |
| 52W High(₹) | 14.08 |
| 52W Low(₹) | 5.67 |
| MCap/Sales | 1.13 |
| Beta(1 Month) | 0.92 |
| BV/Share(₹) | 9.90 |
Lasa Supergenerics share price insights
Undertaking New Debt
Company has outstanding debt obligations for the first time in last 5 years. (Source: Standalone Financials)PAT: Troublesome Times
Company has posted a loss of Rs 4.16 cr for the 4th consecutive quarter. (Source: Standalone Financials)Employee & Interest Expense
Company has spent 1.54% of its operating revenues towards interest expenses and 8.63% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)Lasa Supergenerics Share Price Update
Lasa Supergenerics Ltd. share price moved up by 1.06% from its previous close of Rs 7.60. Lasa Supergenerics Ltd. stock last traded price is 7.68
Share Price Value Today/Current/Last 7.68 Previous Day 7.60
Found Insights useful?
Lasa Supergenerics Share Price Returns
| 1 Day | 1.06% |
| 1 Month | -0.26% |
| 3 Months | 5.35% |
| 1 Year | -29.61% |
| 3 Years | -66.46% |
| 5 Years | -90.55% |
Lasa Supergenerics Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
News & Analysis
Financials
Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Total Income -0.09 2.22 3.07 20.15 41.53 Total Income Growth (%) -104.10 -27.73 -84.77 -51.49 25.01 Total Expenses 3.76 4.52 8.63 42.66 63.54 Total Expenses Growth (%) -16.81 -47.66 -79.77 -32.86 136.73 EBIT -3.85 -2.30 -5.56 -22.51 -22.01 EBIT Growth (%) - - - - -444.87 Profit after Tax (PAT) -4.16 -2.55 -6.25 -21.12 -14.29 PAT Growth (%) - - - - -360.13 EBIT Margin (%) 0.00 -103.72 -181.26 -111.75 -53.00 Net Profit Margin (%) 0.00 -115.22 -203.77 -104.83 -34.41 Basic EPS (₹) -0.83 -0.51 -1.25 -4.22 -2.85 All figures in Rs Cr, unless mentioned otherwise
InsightsPAT: Troublesome Times
Company has posted a loss of Rs 4.16 cr for the 4th consecutive quarter. (Source: Standalone Financials)Employee & Interest Expense
Company has spent 1.54% of its operating revenues towards interest expenses and 8.63% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)
Annual FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 Total Assets 66.27 101.53 150.87 163.86 199.21 Total Assets Growth (%) -34.73 -32.70 -7.93 -17.75 -4.16 Total Liabilities 16.65 17.82 54.19 45.57 50.57 Total Liabilities Growth (%) -6.57 -67.12 18.92 -9.89 3.33 Total Equity 49.62 83.71 96.68 118.29 148.63 Total Equity Growth (%) -40.72 -13.42 -18.27 -20.41 -6.47 Current Ratio (x) 0.62 1.90 0.78 0.92 1.65 Total Debt to Equity (x) 0.20 0.00 0.00 0.00 0.00 Contingent Liabilities 0.00 - - - - All figures in Rs Cr, unless mentioned otherwise
InsightsUndertaking New Debt
Company has outstanding debt obligations for the first time in last 5 years. (Source: Standalone Financials)
Annual FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 Net Cash flow from Operating Activities -0.07 -2.82 2.14 -17.30 10.49 Net Cash used in Investing Activities 0.34 8.15 -0.40 11.19 -3.25 Net Cash flow from Financing Activities -0.25 -5.66 -1.93 -4.16 -0.04 Net Cash Flow 0.01 -0.33 -0.19 -10.27 7.20 Closing Cash & Cash Equivalent 0.29 0.28 0.61 0.80 11.04 Closing Cash & Cash Equivalent Growth (%) 4.54 -54.77 -23.88 -92.76 187.62 Total Debt/ CFO (x) -132.26 0.00 0.00 0.00 0.00 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 Return on Equity (%) -68.69 -17.62 -22.47 -32.65 -3.61 Return on Capital Employed (%) -26.63 -1.21 -8.24 -15.03 1.08 Return on Assets (%) -51.44 -14.53 -14.40 -23.57 -2.69 Interest Coverage Ratio (x) -18.56 4.19 1.17 -1.15 389.33 Asset Turnover Ratio (x) 0.30 1.13 0.66 0.71 0.67 Price to Earnings (x) -0.83 -5.72 -5.07 -2.40 -31.65 Price to Book (x) 0.57 1.01 1.14 0.78 1.14 EV/EBITDA (x) -5.23 7.42 47.93 -18.82 9.71 EBITDA Margin (%) -28.50 7.91 2.17 -3.69 11.44 InsightsLosing Shareholder's Money
Company has reported a negative ROE for 3 consecutive years. (Source: Standalone Financials)
Found Financials useful?
Technicals
No Data Available
R1 - Pivot -
S1 - R2 - S2 - R3 - S3 - 5 Days 14 Days 28 Days - - -
Peer Comparison
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Choose from Peers
Choose from Stocks
Mutual Funds Ownership
No Data Available
Lasa Supergenerics Top Searches
Corporate Actions
Board Meeting
Audited Results
May 19, 2026
Board Meeting
Quarterly Results
Feb 03, 2026
Board Meeting
Quarterly Results
Nov 06, 2025
Announced on Meeting on May 19, 2026 May 29, 2026 Audited Results Feb 03, 2026 Feb 13, 2026 Quarterly Results Nov 06, 2025 Nov 14, 2025 Quarterly Results Aug 05, 2025 Aug 13, 2025 Quarterly Results May 26, 2025 May 28, 2025 Audited Results Announced on Ex-Date Dividend% Apr 11, 2022 Sep 16, 2022 2% May 31, 2021 Sep 15, 2021 2% No Data Available
No Data Available
No Data Available
Announced on Meeting on Sep 15, 2025 Sep 30, 2025 - Aug 01, 2025 Sep 04, 2025 - Jan 30, 2025 Feb 22, 2025 - Sep 10, 2024 Sep 27, 2024 A.G.M. Sep 05, 2023 Sep 27, 2023 A.G.M.
About Lasa Supergenerics
Industry
Key Indices Listed On
-
Address
Plot No C-4, C-4/1, MIDC,Lote Parshuram Industrial Area,Tal: Khed,Ratnagiri Dist., Maharashtra - 415722
Executive Leadership
Omkar Pravin Herlekar
Chairman & Managing DirectorPrathamesh Chalke
Whole Time DirectorKetan Bhau Songal
Independent DirectorPravin Gadalya Lachake
Independent DirectorAuditors
FAQs about Lasa Supergenerics share
- 1. What is Lasa Supergenerics share price and what are the returns for Lasa Supergenerics share?Lasa Supergenerics share price is Rs 7.68 as on 18 Jun, 2026, 11:32 AM IST. Lasa Supergenerics share price is up by 1.06% based on previous share price of Rs. 7.44.
- 2. What is the market cap of Lasa Supergenerics?Lasa Supergenerics share has a market capitalization of Rs 38.53 Cr. Within Chemicals sector, it's market cap rank is 104.
- 3. What are the returns for Lasa Supergenerics share?Return Performance of Lasa Supergenerics Shares:
- 1 Week: Lasa Supergenerics share price moved up by 6.96%
- 4. What is Lasa Supergenerics's 52 week high / low?52 Week high of Lasa Supergenerics share is Rs 14.08 while 52 week low is Rs 5.67
- 5. What is the PE & PB ratio of Lasa Supergenerics?The PE ratio of Lasa Supergenerics stands at -1.12, while the PB ratio is 0.77.
Top Gainers
As on 12:02 PM | 18 Jun 2026Top Losers
As on 12:02 PM | 18 Jun 2026Trending in Markets
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.